<DOC>
	<DOCNO>NCT00568321</DOCNO>
	<brief_summary>This study test efficacy safety two dos level RN624 versus placebo relief pain cause post-herpetic neuralgia ( PHN ) .</brief_summary>
	<brief_title>RN624 For Pain Of Post-Herpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Male female race , least 18 year age . Patients must pain present 3 month heal herpes zoster skin rash . Has pain score screening qualifies . Completes least 3 average daily pain diary 3 day prior randomization average pain level qualifies . Body Mass Index less equal 39 kg/m2 . If female , postmenopausal , surgically sterile , use adequate contraception consist 2 form birth control , one must barrier method , lactate , breastfeed . Male patient must agree female spouses/partners use contraception define nonchildbearing potential ( postmenopausal surgically sterile ) . Patients must willing able comply schedule visit , treatment plan , laboratory test , study procedure . Patients must consent write participate study . Patients discontinue use pain medication screen period study . Disqualifying score questionnaire . Other moderate severe pain condition . History allergic anaphylactic reaction antibody . Use biologics , include live vaccine within 3 month week prior baseline visit . Unable use acetaminophen . Disqualify laboratory value , Hepatitis B C HIV . Patients stroke TIAs , dementia , epilepsy seizure , peripheral neuropathy condition . Significant cardiac disease within 3 month study angina , heart attack , congestive heart failure , cardiac problem . Cancer basal cell squamous cell carcinoma . Fails urine test illegal drug include prescription drug without prescription . Plans surgery study . History alcoholism drug abuse past two year . Surgery postherpetic neuralgia . Any condition investigator feel would put safety patient risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>monoclonal antibody</keyword>
</DOC>